Navigation Links
Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C

clinical investigations of small numbers of patients will not be reflected in clinical trials involving larger numbers of patients, that unexpected and adverse outcomes in other ongoing clinical and nonclinical studies will occur, that the FDA or other regulatory authorities will require additional and unanticipated studies or clinical trial outcomes before granting regulatory approval, and other risks listed under Risk Factors in Vertex's Form 10-K filed with the Securities and Exchange Commission on March 1, 2007. Vertex disclaims any obligation to update the information contained in this press release as new data become available.

(VRTX-G)

Contact

Vertex Pharmaceuticals Incorporated
Lynne H. Brum, 617-444-6614
VP, Strategic Communications
or
Michael Partridge, 617-444-6108
Director, Corporate Communications
or
Patricia Farrell, 617-444-6533
Director, Public Relations
or
Lora Pike, 617-444-6755
Manager, Investor Relations
or
Zachry Barber, 617-444-6470
Senior Media Relations Specialist
or
Tibotec Pharmaceuticals, Ltd.
Karen Manson, Mobile: +32 479 894 799
VP Communications and Public Affairs
Office: +32 15 461 019


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Post Your Comments:
(Date:9/18/2014)... MELBOURNE, Australia , Sept. 18, 2014 ... appointments of Dr. Ashraf Hanna , M.D., Ph.D., ... its Board of Directors. Dr. Hanna is the Vice ... and Chief Financial Officer for the Genentech Foundation, while ... Global Head of Business Development and Licensing for Roche ...
(Date:9/18/2014)... , Sept. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... to the position of  Senior Director of Clinical Development. ... Mr. James has established and led successful global clinical ... , to facilitate the clinical development of numerous ...
(Date:9/18/2014)... Sept. 18, 2014 /CNW/ - A new expert panel report, ... , released today by the Council of ... effective medicines for children. Each year about half of ... at least one prescription drug. Much of this prescribing ... authorized use), creating potential health risks. Children ...
Breaking Medicine Technology:Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 2Studying medicines in children is always possible and is in their best interest, finds Expert Panel 3
(Date:9/18/2014)... 18, 2014 Alexandria, VA — The ... that 10 more communities have joined the growing ranks ... department accreditation. The decisions bring the number of governmental ... PHAB is the non-profit organization that administers the national ... protect the health of the public by advancing the ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Older people ... That,s because the balance of stress hormones during ... result, older people who are grieving are more likely ... study found. "During the difficult weeks and months ... Neutrophils are the most abundant type of white blood ...
(Date:9/18/2014)... San Luis Obispo, CA (PRWEB) September 18, 2014 ... Bunion Bootie introduced their newest, patent pending bunion splint ... , As one loyalist, Rosa, wrote: "I was absolutely delighted. ... comfortable... I honestly forget I am wearing them. THANK YOU ... the recently introduced design by saying, "The hole used to ...
(Date:9/18/2014)... Alan Mozes HealthDay Reporter ... it comes to emergency room waiting times, patients seeking care ... staring down the clock than those seen at smaller or ... crowding and our ability to provide timely emergency care varies ... the authors of the new research, Dr. Renee Hsia, an ...
(Date:9/18/2014)... Physicians (CHEST) together with the Chinese Thoracic Society ... CTS that CHEST World Congress 2016 will be ... care, and sleep medicine from around the world ... for spring 2016. , CHEST World Congress ... simulation training, keynote addresses, presentations by leading health-care ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3Health News:ER Waiting Times Vary Significantly, Studies Find 2Health News:ER Waiting Times Vary Significantly, Studies Find 3Health News:CHEST announces China as site of CHEST World Congress 2016 2
... Research from the University of Sheffield has found that people are ... per year, for greener urban spaces. Researchers surveyed the public ... find out how much extra they were willing to pay in ... area. They found that people were willing to pay more for ...
... group of researchers at the University of California, San Francisco ... and red serpent called the Texas coral snake can be ... and acute pain and provides new research tools that ... The venom contains a toxic mixture of chemicals that includes ...
... , THURSDAY, Nov. 17 (HealthDay News) -- Young athletes who ... -- even if they do not suffer a concussion, according ... from the University of Rochester Medical Center (URMC) said their ... consequences of seemingly mild head injuries among young people whose ...
... -- An international team of researchers led by clinicians at ... in an aggressive type of prostate cancer -- a vulnerability ... is already in clinical trials to treat other types of ... the researchers report that the investigational drug had a dramatic ...
... Gordon HealthDay Reporter , WEDNESDAY, Nov. 16 ... mofetil (CellCept) is better at controlling a serious kidney ... new study suggests. People taking mycophenolate were about ... were people taking azathioprine (Imuran), according to the researchers. ...
... Gardner HealthDay Reporter , WEDNESDAY, Nov. 16 (HealthDay ... healthy have a good chance of staving off cancer as ... maintain a healthy body-mass index (BMI), normal blood pressure and ... a 38 percent lower risk of developing cancer, according to ...
Cached Medicine News:Health News:Public willing to pay more for greener urban spaces 2Health News:Public willing to pay more for greener urban spaces 3Health News:Snake spills venomous secrets 2Health News:Snake spills venomous secrets 3Health News:Routine Head Hits in Sports May Injure Brain, Experts Warn 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 2Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 3Health News:Researchers discover Achilles' heel in lethal form of prostate cancer 4Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 2Health News:Newer Drug Seems Better at Controlling Lupus Kidney Complication 3Health News:Healthy Heart Habits May Also Guard Against Cancer 2Health News:Healthy Heart Habits May Also Guard Against Cancer 3
... This sleek, contoured instrument table ... room dcor, while providing a sturdy, ... wheelchair compatible design provides completely open ... make positioning quick and easy. The ...
... projection, in shorter exam lanes, where images from ... Thirty individual charts are available. Charts are controlled ... the CV-3000 Vision Testing System, using the CV ... either a single letter, horizontal line or vertical ...
... new product has generated lots of interest, ... most efficient instruments in Ophthalmology and Optometry ... system can present the auto refractor values ... space efficiencyfits comfortably in a 7' X ...
... Topcon offers an all-metal Trial Frame that ... a practical screw-thread design that extends the ... for easy replacement of springs and other ... frame snugly yet comfortably on the patients ...
Medicine Products: